Lunai Bioworks Inc.
RENB · NASDAQ
6/30/2025 | 6/30/2024 | 6/30/2023 | 6/30/2022 | |
|---|---|---|---|---|
| Market Cap | $477,029 | $150,147 | $31,902 | $101,379 |
| - Cash | $93 | $220 | $1,874 | $9,172 |
| + Debt | $10,173 | $3,787 | $5,594 | $7,016 |
| Enterprise Value | $487,110 | $153,713 | $35,622 | $99,223 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | -$122 | -$113 | -$124 |
| % Margin | – | – | – | – |
| EBITDA | -$188,837 | -$79,517 | -$38,990 | -$112,937 |
| % Margin | – | – | – | – |
| Net Income | -$178,007 | -$80,650 | -$39,684 | -$113,433 |
| % Margin | – | – | – | – |
| EPS Diluted | -1.08 | -8.4 | -7.1 | -21.6 |
| % Growth | 87.1% | -18.3% | 67.1% | – |
| Operating Cash Flow | -$7,875 | -$10,971 | -$11,775 | -$15,732 |
| Capital Expenditures | $0 | -$70 | -$30 | -$5 |
| Free Cash Flow | -$7,875 | -$11,042 | -$11,804 | -$15,737 |